Search Results

Creating value with financially adaptive clinical trials.

• Authors : David FS; Pharmagellan, 499 Adams Street, Box 94, Milton, Massachusetts 02186, USA.; Bobulsky S

Subjects: Clinical Trials as Topic/Clinical Trials as Topic/Clinical Trials as Topic/*economics ; Drug Industry/Drug Industry/Drug Industry/*economics ; Research/Research/Research/*economics

• Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2015 Aug; Vol. 14 (8), pp. 523-4. Date of Electronic Publication: 2015 Jul 24.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Firms discovering reality of clinical research in India.

• Authors : Jayaraman KS

Subjects: Clinical Trials as Topic*; Drug Industry/Drug Industry/Drug Industry/*legislation & jurisprudence ; Research/Research/Research/*organization & administration

• Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2006 Jan; Vol. 5 (1), pp. 6.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Print ISSN: 1474-1776

Record details

Pharmaceutical futures: made in China?

• Authors : Cyranoski D

Subjects: Drug Industry/Drug Industry/Drug Industry/*organization & administration ; Drug Industry/Drug Industry/Drug Industry/*trends ; Outsourced Services/Outsourced Services/Outsourced Services/*organization & administration

• Source: Nature [Nature] 2008 Oct 30; Vol. 455 (7217), pp. 1168-70.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Innovative drug R&D in China.

• Authors : Qi J; Wang Q; Yu Z

Subjects: Drug Design*; Drug Industry/Drug Industry/Drug Industry/*trends ; Research/Research/Research/*trends

• Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2011 May; Vol. 10 (5), pp. 333-4.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Record details

Bioethics. Financial conflicts get more scrutiny in clinical trials.

• Authors : Agnew B

Subjects: Bioethics* ; Drug Industry*/Drug Industry*/Drug Industry*/economics; Clinical Trials as Topic/Clinical Trials as Topic/Clinical Trials as Topic/*standards

• Source: Science (New York, N.Y.) [Science] 2000 Aug 25; Vol. 289 (5483), pp. 1266-7.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

When Pharma merges, R&D is the dowry.

• Authors : Agnew B

Subjects: Drug Design* ; Drug Industry*/Drug Industry*/Drug Industry*/economics ; Drug Industry*/Drug Industry*/Drug Industry*/organization & administration

• Source: Science (New York, N.Y.) [Science] 2000 Mar 17; Vol. 287 (5460), pp. 1952-3.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

Pharmaceutical medicine. [electronic resource].

• Authors : Society of Pharmaceutical Medicine.; International Federation of Associations of Pharmaceutical Physicians.

Subjects: Drugs -- Testing -- Periodicals; Pharmacy -- Research -- Periodicals; Clinical trials -- Periodicals

Record details

De la plus-value therapeutique au surcout d'un nouveau medicament: a propos d'un hiatus croissant.

• Authors : Scheen, André

Subjects: Clinical Trials as Topic; Delivery of Health Care/economics; Drug Approval

• Source: Revue Médicale Suisse, 1(30), 1931-2. Switzerland (2005).

Record details

Coronavirus disruptions reverberate through research.

• Authors : Servick K; Cho A; Couzin-Frankel J

Subjects: Biomedical Research* ; Pandemics* ; Research*

• Source: Science (New York, N.Y.) [Science] 2020 Mar 20; Vol. 367 (6484), pp. 1289-1290.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

Stem-cell discovery platforms yield first clinical candidates.

• Authors : Mullard A

Subjects: Clinical Trials as Topic*/Clinical Trials as Topic*/Clinical Trials as Topic*/methods; Drug Industry/Drug Industry/Drug Industry/*trends ; Induced Pluripotent Stem Cells/Induced Pluripotent Stem Cells/Induced Pluripotent Stem Cells/*transplantation

• Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2015 Sep; Vol. 14 (9), pp. 589-91.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Record details